[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
October 6, 1962

Current Knowledge of Influenza Vaccine

Author Affiliations

Ann Arbor, Mich.
From the Department of Epidemiology and Virus Laboratory, School of Public Health, University of Michigan.

JAMA. 1962;182(1):11-13. doi:10.1001/jama.1962.03050400013003

When potent vaccines of appropriate antigenic composition are used properly, an important degree of protection against epidemic influenza is assured. Knowledge accumulated concerning the toll exacted by epidemics of influenza recommends extension of coverage of the population by vaccination. That recommendation is especially pertinent this year, since it seems likely that a widespread epidemic of Asian influenza will occur in the United States during 1962-1963. Specific indications concerning dosage, route, schedules, and types of patients requiring first consideration are given.

Davenport, F. M.:  Inactivated Influenza Virus Vaccines; Past, Present, and Future ,  Amer Rev Resp Dis 83:146-150, 1961.
Meiklejohn, G.:  Adjuvant Influenza Adenovirus Vaccine ,  JAMA 179:594-597, 1962.Crossref
 International Conference on Asian Influenza ,  Amer Rev Resp Dis 83:1-219, 1962.
Davenport, F. M.:  Recent Advances in Prevention of Influenza by Vaccination ,  Mod Med 26:115-122, 1958.
Eickhoff, T. C.; Sherman, I. L.; and Serfling, R. E.:  Observations on Excess Mortality Associated with Epidemic Influenza ,  JAMA 176:776-782, 1961.Crossref
McCarroll, J. R., and Kilbourne, E. D.:  Immunization with Asian Strain Influenza Vaccine ,  New Engl J Med 259:618-621, 1958.Crossref
Salk, J. E.:  Reactions to Concentrated Influenza Virus Vaccines ,  J Immun 58:369-395, 1948.
Griffin, H. E.:  Reactions to Influenza Vaccine ,  Ann Allergy 17:179-187, 1959.
 Communicable Disease Center , Influenza Surveillance Report No. 72, (May 31) , 1962, U.S. Dept. of Health, Education, and Welfare, Public Health Service.